“Dr. Arnold Klein is worldwide acknowledged as the best and first! All doctors I know say the same.” –Angelika Taschen
Dr. Arnold William Klein was born on February 27, 1945 in Mt. Clemens, Michigan and was raised in Michigan and Miami, Florida. He graduated cum laude with a Bachelor of Arts degree in Biology from the University of Pennsylvania in 1967. In 1971, he graduated cum laude and Phi Beta Kappa from the University of Pennsylvania, School of Medicine. Dr. Klein completed his post-graduate education as a medical intern at Cedars-Sinai Medical Center in Los Angeles and went on to complete medical residencies in dermatology at the Hospital of the University of Pennsylvania and the University of California at Los Angeles where he was the Chief Resident in Dermatology in 1975.
For over 30 years, Dr. Klein has offered the very best in dermatology and cosmetic surgery. He is considered the father of modern cosmetic dermatology and has been in the forefront of the latest treatments in this field, including developing minimally invasive injection techniques for physical enhancements such as Botox, Collagen and Restylane that are used around the world today. He has received numerous awards and honors, including recognition in Who’s Who in the World, Best Doctors in America and Men of Achievement.
Not only does Dr. Klein run a very busy, prestigious practice, but he’s also a Professor of Medicine and Dermatology at the David Geffen School of Medicine at UCLA and an emeritus attending physician at the Cedars-Sinai Medical Center in Los Angeles. In addition, The UCLA Division of Dermatology named an endowed chair to honor Dr. Klein. The Arnold Klein, MD Chair in Dermatology promotes the rapid application of basic science and clinical research discoveries to the development of new dermatology therapies.
Throughout his career, Dr. Klein has been deeply involved in philanthropy. In the early days of the AIDS crisis, Dr. Klein was the first physician to diagnose a case of Kaposi’s sarcoma in Southern California. This was the beginning of what has become a 25-year commitment to treating and finding a cure for AIDS. In 1984, in the living room of his Los Angeles home, Dr. Klein, along with David Geffen, Dr. Mathilde Krim, and others founded the American Foundation for AIDS Research (amfAR). Dr. Klein continues to serve as the Founding Member and Director. Most recently, in honor of his dear friend Dame Elizabeth Taylor, Dr. Klein established the endowment for the Elizabeth Taylor Center for AIDS Research, Treatment and Education at UCLA, a facility with an international reputation in HIV/AIDS care. In an article related to AIDS in Africa in the November 2008 issue of L’Uomo Vogue, it was reported that Dr. Klein and the organizations he founded have raised in excess of 274 million dollars for HIV research and care.
Dr. Klein also serves as a Trustee to numerous Boards of Directors, including the Jennifer Jones-Simon Foundation, the UCLA Center for the Health Sciences, and The Hereditary Disease Foundation. The Hereditary Disease Foundation discovered the first gene for Huntington’s chorea. Dr. Klein, along with his longtime friend Frank Gehry, works with the foundation to raise funds and awareness for inherited diseases. Dr. Klein is also the founder of the Rose-Tarlow-Arnold W. Klein Breast Cancer Foundation at UCLA, established to provide breast cancer treatment for individuals who are unable to afford it.
Dr. Klein has published nearly 150 scientific papers in such prestigious peer-reviewed journals as the New England Journal of Medicine, Science Magazine and JAMA. He has written four medical textbooks, including his most recent, “Tissue Augmentation in Clinical Practice”, second Edition. Additionally, he has written numerous textbook chapters on Cosmetic Dermatology, Soft Tissue Augmentation, Aesthetic Surgery and Botulinum Toxin. He also serves and has served on the Editorial Board and as Expert Reviewer of numerous national and international medical publications, including the Journal of Plastic and Reconstructive Surgery, Journal of the American Academy of Dermatology, Dermatologic Surgery, Archives of Dermatology, Aesthetic Surgery, Aesthetic Buyers Guide, British Journal of Dermatology and the Journal of Cutaneous Aging and Cosmetic Dermatology, to name a few.
Dr. Klein has also served as an advisor, consultant, and principal investigator to Allergan, Anika, Elan Pharmaceuticals, Ethicon, Genzyme, Johnson & Johnson, Medicis Aesthetics, Ortho-Neutrogena, Skin-Medica and Q-Med.